CDO1 and gastric cancer: Gastric cancer patients were divided into two groups of H group (n = 47): high CDO1 TaqMeth V group (TaqMeth V ≥ 32.6) and L group (n = 91): low CDO1 TaqMeth V group (TaqMeth V <32.6).